Cargando…
Creatine consumption and liver disease manifestations in individuals aged 12 years and over
Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross‐sectional population‐based study was to evaluate the association between cr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922125/ https://www.ncbi.nlm.nih.gov/pubmed/36789045 http://dx.doi.org/10.1002/fsn3.3151 |
_version_ | 1784887475068469248 |
---|---|
author | Todorovic, Nikola Korovljev, Darinka Stajer, Valdemar Jorga, Jagoda Ostojic, Sergej M. |
author_facet | Todorovic, Nikola Korovljev, Darinka Stajer, Valdemar Jorga, Jagoda Ostojic, Sergej M. |
author_sort | Todorovic, Nikola |
collection | PubMed |
description | Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross‐sectional population‐based study was to evaluate the association between creatine intake through regular diet and liver disease manifestations, including liver fibrosis and hepatic steatosis, among individuals aged 12 years and over, using open‐source data from the 2017–2018 U.S. National Health and Nutrition Examination Survey (NHANES). A total of 9254 male and female participants of all ages were included in the 2017–2018 NHANES round. We extracted data from the total sample population for participants who provided dietary data for individual foods via dietary interviews and examination data from liver ultrasound transient elastography. The final study sample consisted of 5957 participants (mean age 44.7 ± 21.0 years; 50.1% women), and the mean dietary creatine intake across the study population was 0.88 ± 0.71 g/day. Liver fibrosis and cirrhosis were diagnosed in 1703 (28.7%) and 288 (4.8%) participants, respectively; hepatic steatosis was identified in 2595 (43.7%) individuals. Binary logistic regression with multivariable model adjusted for age, gender, family income to poverty ratio, body mass index, total energy intake, and alcohol consumption showed that consuming more creatine (≥2 g/day) did not significantly increase the risk of liver fibrosis (OR = 0.92, 95% CI 0.70–1.21, p = .57), cirrhosis (OR = 0.94, 95% CI 0.53–1.65, p = .82), or hepatic steatosis (OR = 0.77, 95% CI 0.59–1.02, p = .07), as compared to participants who ingested <1 g of creatine daily. Dietary exposure to creatine through a regular diet is not associated with an increase in disease manifestations in individuals 12 years and over; further research is warranted to address the effects of excessive creatine intake (≥5 g/day) through a regular diet on liver health at the population level. |
format | Online Article Text |
id | pubmed-9922125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99221252023-02-13 Creatine consumption and liver disease manifestations in individuals aged 12 years and over Todorovic, Nikola Korovljev, Darinka Stajer, Valdemar Jorga, Jagoda Ostojic, Sergej M. Food Sci Nutr Original Articles Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross‐sectional population‐based study was to evaluate the association between creatine intake through regular diet and liver disease manifestations, including liver fibrosis and hepatic steatosis, among individuals aged 12 years and over, using open‐source data from the 2017–2018 U.S. National Health and Nutrition Examination Survey (NHANES). A total of 9254 male and female participants of all ages were included in the 2017–2018 NHANES round. We extracted data from the total sample population for participants who provided dietary data for individual foods via dietary interviews and examination data from liver ultrasound transient elastography. The final study sample consisted of 5957 participants (mean age 44.7 ± 21.0 years; 50.1% women), and the mean dietary creatine intake across the study population was 0.88 ± 0.71 g/day. Liver fibrosis and cirrhosis were diagnosed in 1703 (28.7%) and 288 (4.8%) participants, respectively; hepatic steatosis was identified in 2595 (43.7%) individuals. Binary logistic regression with multivariable model adjusted for age, gender, family income to poverty ratio, body mass index, total energy intake, and alcohol consumption showed that consuming more creatine (≥2 g/day) did not significantly increase the risk of liver fibrosis (OR = 0.92, 95% CI 0.70–1.21, p = .57), cirrhosis (OR = 0.94, 95% CI 0.53–1.65, p = .82), or hepatic steatosis (OR = 0.77, 95% CI 0.59–1.02, p = .07), as compared to participants who ingested <1 g of creatine daily. Dietary exposure to creatine through a regular diet is not associated with an increase in disease manifestations in individuals 12 years and over; further research is warranted to address the effects of excessive creatine intake (≥5 g/day) through a regular diet on liver health at the population level. John Wiley and Sons Inc. 2022-11-18 /pmc/articles/PMC9922125/ /pubmed/36789045 http://dx.doi.org/10.1002/fsn3.3151 Text en © 2022 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Todorovic, Nikola Korovljev, Darinka Stajer, Valdemar Jorga, Jagoda Ostojic, Sergej M. Creatine consumption and liver disease manifestations in individuals aged 12 years and over |
title | Creatine consumption and liver disease manifestations in individuals aged 12 years and over |
title_full | Creatine consumption and liver disease manifestations in individuals aged 12 years and over |
title_fullStr | Creatine consumption and liver disease manifestations in individuals aged 12 years and over |
title_full_unstemmed | Creatine consumption and liver disease manifestations in individuals aged 12 years and over |
title_short | Creatine consumption and liver disease manifestations in individuals aged 12 years and over |
title_sort | creatine consumption and liver disease manifestations in individuals aged 12 years and over |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922125/ https://www.ncbi.nlm.nih.gov/pubmed/36789045 http://dx.doi.org/10.1002/fsn3.3151 |
work_keys_str_mv | AT todorovicnikola creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover AT korovljevdarinka creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover AT stajervaldemar creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover AT jorgajagoda creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover AT ostojicsergejm creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover |